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Abstract
Background: People with serious mental illnesses (SMI) such as schizophrenia often also have physical health
illnesses and interventions are needed to address the resultant multimorbidity and reduced life expectancy.
Research has shown that volunteers can support people with SMI. This protocol describes a feasibility randomised
controlled trial (RCT) of a novel intervention involving volunteer ‘Health Champions’ supporting people with SMI to
manage and improve their physical health.
Methods: This is a feasibility hybrid II randomised effectiveness-implementation controlled trial. The intervention
involves training volunteers to be ‘Health Champions’ to support individual people with SMI using mental health
services. This face-to-face or remote support will take place weekly and last for up to 9 months following initial
introduction. This study will recruit 120 participants to compare Health Champions to treatment as usual for people
with SMI using secondary community mental health services in South London, UK. We will measure the clinical and
cost effectiveness including quality of life. We will measure the implementation outcomes of acceptability,
feasibility, appropriateness, fidelity, barriers and enablers, unintended consequences, adoption and sustainability.
Discussion: There is a need for interventions to support people with SMI with their physical health. If this feasibility
trial is successful, a definitive trial will follow to fully evaluate the clinical, cost and implementation effectiveness of
Health Champions supporting people with SMI.
Trial registration: ClinicalTrials.gov, registration no: NCT04124744.
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Background
People diagnosed with a serious mental illness (SMI)
such as schizophrenia, bipolar disorder and major
depression have poorer physical health and experience
more multimorbidity than the general population [1–3].
People with SMI have higher rates of cardiovascular dis-
ease [4], diabetes [5] and respiratory disease [6]. Recent
research has shown that this health gap is widening [2].
The reasons for this inequality are complex, encom-
passing individual, health service and societal factors [7].
Individual level factors include severity of illness and
symptoms which can affect how people access help. The
health service factors include fragmentation of physical
and mental health services, the impact of cuts in ser-
vices, and ‘diagnostic overshadowing’ where physical
health symptoms are seen as part of mental illness by
health professionals. Social factors include stigma,
poverty, poor housing [7] and social isolation [8]. There
is a clear need for interventions that promote the
physical health of this population at all of these levels
[9]. Solutions need to be flexible enough to meet the
needs of individual service users and this can be difficult
in England within over-stretched primary care and
mental health services [10].
There is little evidence on how best to support people
with SMI to manage their physical health. A Cochrane
review of physical health advice for service users with
SMI demonstrated a modest improvement in quality of
life [11]. However, the review also highlighted a signifi-
cant research gap in assessing physical health advice
interventions and their impact on service users’ physical
health. This research gap was also found in a recent
systematic review of physical health screening in this
population [12]. A recently published Lancet Psychiatry
Commission summarises the best available evidence for
interventions targeting specific health outcomes such as
smoking and obesity and advocates community-based
interventions [13].
In this protocol, we describe a novel intervention in
which volunteers will work alongside people using
community mental health services for up to 9 months to
support them with managing their physical health. There
is emerging literature on the benefits of mental health
service users being supported by volunteers both for the
service user and volunteer. For service users, this
includes contact with someone non-judgemental who
helps facilitate increased social interaction, and for
volunteers, the feeling they are giving something back
and helping others [14–16]. However, there is little
evidence regarding volunteers working with service users
specifically on their physical health. This study aims to
contribute to this much needed area by evaluating the
introduction of volunteer ‘Health Champions’ who are
matched with service users to support them in the
community in setting and working towards their own
defined physical health goals as part of a randomised
controlled trial.
The aims of this study are to evaluate the feasibility of
deploying trained volunteer ‘Health Champions’ to sup-
port people with SMI in managing their physical health,
compared to treatment as usual. We aim to collect clin-
ical, economic and implementation measures to assess
the feasibility and to understand the implementation
challenges of undertaking the intervention in routine
practice.
As the study will start during the COVID-19
pandemic, contacts will be face-to-face or remote, in line
with contemporaneous national and local guidance and
approvals.
Development of the intervention
Phase 1 (February 2018-January 2019): Initial
conceptualisation
The intervention was developed as part of a larger
‘Integrated Mental and Physical Health Systems’ (IMPHS)
Programme funded by the Maudsley Charity and involving
SLaM service users and providers. The initial conceptual-
isation of the intervention came from discussion between
the Maudsley Charity, the SLaM Volunteer Manager and
the IMPHS project scientists. SLaM volunteers already
support people in a variety of ways including befriending
and the scope to use volunteers to support physical health
was developed into an idea for an intervention. Advice was
sought from the King’s Health Partners (KHP) Mind and
Body Programme Expert Advisory Group and the SLaM
Serious Mental Illness Service User Group as part of the
initial development of the Health Champions project.
Phase 2 (February-October 2019): Development of a theory
of change
Initial conceptualisation of the intervention was followed
by development of a Theory of Change (ToC) for the
study. A draft ToC was produced by the IMPHS project
team, which was subsequently reviewed and refined in
two stakeholder workshops (on 30 September and 1
October 2019) with 22 participants. ToC workshop
participants were service users, carers, clinical staff,
voluntary sector representatives and volunteers.
The ToC that emerged from this process (see Table 1)
proposes that, by working with a Health Champion, par-
ticipants will improve their own self-management of
their physical health by goal-setting and problem-solving
with their Health Champion. This may lead to improve-
ment in their physical and mental health and a decrease
in their treatment burden. All of these will then lead to
improved physical and mental quality of life. The ToC
also proposes a possible decrease in loneliness both for
the duration of the intervention and afterwards.
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Phase 3 (March 2019-December 2019): Operationalisation
of the intervention
Whilst the ToC was being developed and consulted on,
we finessed and operationalised the intervention. This
included developing the processes for recruiting and
training the volunteers to deliver the intervention (see
Section 2.7.1 for details), and for recruiting people with
SMI as participants into the trial (see Section 2.8).
Feasibility outcomes
We will measure the following feasibility outcomes:
1. Feasibility of the intervention measured using the
Feasibility of Intervention Measure [17] and
qualitative interviews with participants and
Health Champions.
2. Appropriateness of the intervention to both
participants and Health Champions measured using
the Intervention Appropriateness Measure [17] and
qualitative interviews with participants and Health
Champions.
3. Fidelity to the intervention which we will measure
using a content analysis of Health Champions and
participants journals to assess fidelity of the delivery
of the intervention and fidelity of receipt of the
intervention, supervision records, and the number
and percentage of meetings between each Health
Champion and participant.
4. Barriers and facilitators and unintended
consequences will be measured using qualitative
interviews with a subset of 30% participants and
Health Champions chosen at random after the



























































Recruit participants and ensure they
have full details of the intervention
Training of Health Champions
including on how to build
relationships and coaching skills
Support and supervision for Health
Champions during the intervention
Effective matching of Health
Champions and participants
Mapping of voluntary and community
sector organisations
Role of Health Champions
Help to set goals
• To give light-touch education and in-
formation to patients to promote
healthy lifestyles
Specific activities for patient-Health
Champion pairs to do together may
include:
• Encouraging participation and
engagement in healthy hobbies and
activities in the community—for
instance, swimming, walking, use of
gyms/exercise facilities (e.g. park gyms,
and local authority sports centres)
• Taking part in group activities and
exercise—building social networks,
self-esteem and confidence
• Providing tips and guidance around
nutrition, healthy cooking and eating
(including food shopping and food
traffic light systems), and cooking
together
• Helping patients attend follow up GP
or outpatient appointments for
physical health issues
Groups for Health Champions only
and Health Champions and
participants to meet and discuss
intervention/progress/share ideas
Possible teaching sessions for Health




dealing with physical health
including ability to attend
physical health appointments
Increased knowledge of how
to deal with physical health
concerns and problems
Increase in doing things to
improve physical health-e.g.




Reduced levels of social
isolation











Better knowledge of local
community organisations
Improved quality of life
Improved physical health of patients
Improved patient experience and
engagement
Improved links with the voluntary and




patients and carers of physical health
and its interaction with mental health,
and how to promote healthy lifestyles
Increased awareness and
understanding of the types of services
(and who would most benefit)
provided by the voluntary and
community sector
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intervention recording whether the intervention
was delivered face to face or remotely plus details
from the journals and supervision records. We will
also interview all participants who drop out of the
intervention to understand their reasons for this.
5. Adoption of the intervention will be measured by
the number and percentage of participants that
start the intervention, how many sessions they have
and how long (in months) they stay in the
intervention.
6. Adoption and sustainability will also be assessed




This is a feasibility hybrid II effectiveness-implementation
randomised controlled trial. Hybrid type II trials [18] are at
the cutting edge of applied health research and are used to
jointly assess the clinical effectiveness and implementation
strategies of evidence-based interventions so that findings
can be interpreted in the light of how best to implement
such interventions at scale and with sustainability, including
economic viability. The schedule of enrolment, interven-
tions and assessments is shown in Table 2.
Study setting
Participants will be recruited from Community Mental
Health Teams (CMHTs) in the South London and
Maudsley NHS Trust (SLaM: London, UK) working with
people with SMI. The intervention will be delivered in
the community.
Participants
Participants will be people using the participating
CMHTs.
Inclusion criteria
 18 years and older
 Diagnosed with a SMI including schizophrenia,
bipolar disorder, schizoaffective disorder, delusional
and other non-mood psychotic disorders and major
depression
 Has capacity to give written informed consent to
take part in the trial
 Able to provide a named Care Coordinator or other
Point of Contact in the CMHT reachable in the
event of a health crisis
 Wants to make changes to their physical health (we
will ask referrers to have a conversation with anyone
being referred to ask this question and this will also
be asked by the researcher who first contacts the
potential participant)
Exclusion criteria
 Under 18 years of age
 Unable to give informed consent
Ethical approval
Ethical approval for the trial has been obtained from
Brent Research Ethics Committee, REC reference no:
20/LO/0214.
The intervention
Overview of the intervention
We will recruit and train volunteers to act as Health
Champions. These Health Champions will support indi-
vidual service users to set and work towards their own
individually decided physical health goals. They will
meet face-to-face once a week for up to 9 months at a
location decided by the participant and in line with their
goals or remotely depending on the guidance on social
distancing at the time. If the participant reaches their
goals within 9 months, they can choose to end their in-
volvement. The Health Champions will be supported by
a Volunteer Coordinator who will be based in the SLaM
Volunteer team and will be recruited specifically for this
role.
The ‘Health Champions’ intervention
Health Champions will work individually with a matched
service user participant over 9 months, meeting weekly
for a minimum of 1 h to support the participant to set
and work towards their own physical health goal(s).
These meetings will be face-to-face depending on the
guidance at the current time. We will match the Health
Champion and participant based on geographical area
and interests. If participants have a preference in terms
of being matched in terms of age, gender and ethnicity,
we will try to meet this preference.
Once the participant and Health Champion have been
matched, there will be an initial meeting with the Volunteer
Coordinator present (either face-to-face or remotely) to
check if they are happy to work together and answer any
questions.
In the initial face-to-face or remote meeting, the par-
ticipant will be encouraged to set their own physical
health goals with their Health Champion. These goals
will be logged in a ‘Participant Physical Health Journal’
which is a journal held by the participant where they can
record and reflect on their progress. All subsequent
meetings between Health Champions and participants
should aim to help the participant achieve these physical
health goals and log their progress in the ‘Participant
Physical Health Journal’. Health Champions will also be
asked to complete a ‘Health Champions Journal’ to
record their experience as a Health Champion and in
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supporting the person they are working with. The par-
ticipant and their Health Champion will be encouraged
to complete both journals together during a short reflec-
tion period at the end of each weekly session, though
they may complete them separately if they wish to.
These journals are to help participants and Health
Champions record and reflect on the goals set and pro-
gress towards them. They also have a secondary purpose
of helping to evaluate the fidelity of the intervention (see
evaluation section for further details of this). The
intervention will take place in the community with the
specific location being dependent on the goals of the




(at end of intervention
or after 9 months)
Follow-up assessment 2
(6 months after end of
intervention or 9 month
assessment)
Participants
Patient information and informed consent X
Demographics X
EQ-5D-5L X X X
ReQOL X X X
Patient activation measure X X X
Multimorbidity Treatment Burden Questionnaire X X X
De Jong Gierveld Loneliness Scale X X X
Participant goals X X X
Health Questionnaire including number of health
screenings and service use in last 6 months
X X X
Acceptability

















Unintended consequences-interview X X
Experience of the intervention-interview X
Health champions
Acceptability












Barriers and facilitators-interview X
Unintended consequences-interview X
Experience of the intervention-interview X
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participants (for example, if they wish to go to the gym
etc.) if this is possible. If not, meetings will take place
remotely. As this is a feasibility trial, we will record any
tailoring or modifications made by any of the Health
Champions in response to needs or wishes of their
matched participant.
We will also facilitate regular events for Health Cham-
pions and participants to meet other Health Champions
and participants, to share experiences and resources and
provide teaching on particular conditions or activities if
a group of participants emerged through the trial with
the same goals or health conditions to manage.
Procedure
Health Champion recruitment, training and support
SLaM has a well-established Volunteer Department. For
initial Health Champions recruitment, the role of Health
Champions will be advertised to the over 300 volunteers
at SLaM. Health Champions will be recruited in accord-
ance with SLaM policies including DBS/reference checks
and mandatory training for the safeguarding of
vulnerable people, lone-working and boundary setting
for volunteers. Health Champion eligibility criteria:
 18 years and over.
 Disclosure and Barring Service (DBS) checked and
cleared.
 Able to attend the relevant SLaM Volunteer and
Health Champion Programme training and commit
2 h per week for up to 9 months.
To ensure fidelity of the intervention, prior to deploy-
ment, Health Champions will receive 1 day remote train-
ing on the role of the Health Champion which will
include outlining the role of the Health Champion, the
importance of physical health and its link to mental
health, how to work with people to set their own goals,
coaching techniques using the REACH model of coaching
[19] and how to build and end an effective relationship
with a service user. This training will be provided by the
Volunteer Coordinator, research team and experts in
coaching. The Health Champions will also receive
monthly supervision from the Volunteer Coordinator
throughout the study and the opportunity to meet as a
group to share experiences and learn from each other.
This will ensure that they feel confident to work in the
community and develop a good level of knowledge and
expertise around supporting physical health in service
users with SMIs.
The Volunteer Department in SLaM have an existing
process for raising concerns regarding crises, emergen-
cies, safe-guarding and any other issues arising concern-
ing the well-being of volunteers or service users. The
Health Champion volunteers will be required to follow
these processes and raise any issues with the Volunteer
Coordinator and the service user’s Care Coordinator.
The Volunteer Coordinator will be also work with vol-
unteers (not necessarily Health Champions) to identify
resources provided by voluntary sector organisations
(VSOs) in the London boroughs covered by SLaM
(Croydon, Lambeth, Lewisham and Southwark). They
will act as a point of contact to negotiate access to re-
sources where there are gaps, foster new relationships
and link VSOs. Health Champions will be provided with
a database of cost-effective local resources available to
service users to help achieve their physical health goals.
Participant recruitment
We will recruit participants from CMHTs across all four
South London boroughs that are covered by SLaM ser-
vices—namely the boroughs of Lambeth, Lewisham,
Southwark and Croydon. Participants will be recruited
using two methods.
(1).Directly recruited from the community teams by
staff identifying and recruiting people who are
eligible for the study. Staff will be made aware of
the eligibility criteria of the study.
(2).Using the SLaM Consent for Contact (C4C) service
to identify people using CMHTs who have already
consented to be approached by researchers to take
part in research projects.
Once potential participants have been identified, they
will be contacted by a researcher who will explain the pur-
pose and nature of the study to them. If they are interested
in taking part, a researcher will meet with them and give
them the patient information sheet to read and answer
any questions. If possible these meetings will be face-to-
face, if not they will be by telephone or on Microsoft
Teams. If they are still interested in taking part, they will
complete a written consent form. If the meeting is not
face-to-face, consent forms can either be posted to the
participant or they can complete an online consent form.
A baseline assessment will then be done which will also be
either face-to-face or remotely. After this assessment, they
will be allocated to either the intervention or control
group (see “Randomisation” section for details below).
Participants in the intervention group will then follow
the intervention as outlined above. Participants in the
control group will receive a copy of a workbook on man-
aging physical health and a ‘Participant Physical Health
Journal’. Both groups will be asked to complete follow-
up assessments at 9 months and 15 months after
baseline. All participants will be reimbursed £10 for each
assessment, £30 in total.
If any participants lose mental capacity during the
trial, they will be withdrawn from the study.
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Control group
Participants in the control group will receive treatment
as usual from their CMHT regarding their physical
health, and we will record what support participants are
given for their physical health as there is no agreed prac-
tice for this. They will receive a copy of a workbook on
managing physical health which was developed by SLaM
and includes sections on how people can look after their
physical health and well-being at home and details of
physical health tests that can be given when people are
inpatients, and a copy of the ‘Participant Physical Health
Journal’ which is given to participants in the intervention
group.
Randomisation
The randomisation system randomly sequences the
order of the participants and enters them into the study
stratifying by borough. A random number generator will
be used to assign participants to the intervention or the
control arm. A statistician independent of the study will
do this and put the randomised numbers into sealed en-
velopes and give these to the research team. This will be
put into a list that will be concealed from the research
team. When the research team do the initial assessment
with a participant, the envelope will be opened to reveal
which arm of the study the participant is in after the ini-
tial assessment has been completed.
Sample size
As this is a pilot RCT, we will not undertake a power
calculation to calculate the sample size as would be done
in a full RCT. We wish to have a sample size of 100 par-
ticipants—50 in the intervention group and 50 in the
control group. As we know there will be participants
who drop out of the study, we will recruit 120 partici-
pants—60 in the intervention group and 60 in the con-
trol group to account for this drop out. We are basing
this dropout rate partly on a pilot study undertaken with
this population evaluating an intervention to support
people to be more physically active [20]. This sample
size is used due to the resources of the study.
Data collection
Aim 1: Clinical effectiveness of the intervention
Primary outcome
Our primary outcome is physical health-related quality of
life which we will measure using the EQ-5D-5L [21] at
baseline, at the end of the intervention (nine months after
baseline) and 6 months after the end of the intervention.
Secondary outcomes
The following outcomes will be measured at baseline,
and at the end of the intervention (9 months after base-
line) and 6 after the end of the intervention.
1. Self-management using the 10-item Patient
Activation Measure [22].
2. Mental Health related Quality of Life using the
10-item Recovering Quality of Life (ReQoL)
measure [23].
3. Treatment burden using the 10-item Multimorbidity
Treatment Burden Questionnaire [24].
4. Loneliness using the 6-item De Jong Gierveld
Loneliness Scale [25].
5. We will record participant’s use of physical health
services and physical health screenings.
6. We will record demographic information including
age, gender, ethnicity, educational level, living
arrangements, employment status and relationship
status.
Aim 2: Implementation effectiveness of the intervention
Primary outcome
Our primary outcome is acceptability of the intervention
measured using the Acceptability of Intervention
Measure [17].
Feasibility outcomes
1. Feasibility of the intervention measured using the
Feasibility of Intervention Measure [17] and
qualitative interviews with participants and Health
Champions.
2. Appropriateness of the intervention to both
participants and Health Champions measured using
the Intervention Appropriateness Measure [17] and
qualitative interviews with participants and Health
Champions.
3. Fidelity to the intervention which we will measure
using a content analysis of Health Champions and
participants journals to assess fidelity of the delivery
of the intervention and fidelity of receipt of the
intervention, supervision records and the number
and percentage of meetings between each Health
Champion and participant.
4. Barriers and facilitators and unintended
consequences will be measured using qualitative
interviews with a subset of 30% participants and
Health Champions chosen at random after the
intervention recording whether the intervention
was delivered face to face or remotely plus details
from the journals and supervision records. We will
also interview all participants who drop out of the
intervention to understand their reasons for this.
5. Adoption of the intervention will be measured by
the number and percentage of participants that
start the intervention, how many sessions they have
and how long (in months) they stay in the
intervention.
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6. Adoption and sustainability will also be assessed
using interviews with SLaM managers and
commissioners.
Data analysis for aims 1 and 2
Quantitative data
Feasibility studies are not designed to detect a treatment
effect. It is recommended that feasibility trials should
report primarily descriptive statistics on variables that
would inform a larger scale RCT [26, 27]. Our data ana-
lysis plan is conducted on these premises.
The first stage of analyses will be a descriptive model
of the data to assess completeness of data. Participant-
level baseline variables will be described both overall and
by randomised groups and borough. Patterns of missing
data will be described.
The primary outcome will be analysed using linear
mixed models, to model the change in scores in EQ-5D-
5L as a measure of quality of life. The linear mixed
models will be adjusted for baseline total score of EQ-
5D-5L and stratification factors (borough). The model
will use a random intercept to account for clustering. A
two-level hierarchical model will be employed with all
timepoints included as repeated measures in the model
(after intervention and 9 months) to improve power and
to take into account clustering of the observation at
patient and group therapy level within each arm of the
intervention. These models use maximum likelihood es-
timation and thus allow for missing outcome data under
the missing at random (MAR) assumption. Secondary
outcomes will be assessed with a similar methodology
for the primary outcomes, using generalised linear mixed
models depending on the type of outcome (normal, bin-
ary and count). The EQ-5D-5L and other questionnaires
to be used have validated methods of scoring, and the
scores will be analysed as described to capture change
post-intervention and 9-month follow-up (vs. pre-
intervention). As this is a pilot study designed to primary
measure the feasibility of the trial (and is not focusing to
test effectiveness or powered to do so) and to under-
stand if the intervention does impact on the EQ-5D-5L
score within each arm of the intervention, we will use
any potential change observed on the EQ-5D-5L score
to guide a larger trial.
Qualitative data
All interviews will be digitally recorded and transcribed
then fully anonymised interview transcripts will be
produced. Both inductive and deductive coding will be
undertaken so that themes will be determined by the
interview topic guides and will also be unprompted by
the semi-structured nature of the interviews. Thematic
analysis [28] will be used to guide the synthesis of the
qualitative findings.
Aim 3: Health economic evaluation of the intervention
and implementation
An economic evaluation will be used to answer whether
1. The Health Champion approach warrants
scaling-up given available evidence on
implementation and intervention costs, evidence-
based assumptions regarding the effectiveness of
its implementation (e.g. anticipated levels of
population ‘reach’) and likely impact of the
intervention on quality of life and survival in the
short- and longer-term.
2. The extent of uncertainty in how cost-effective it
would be to scale-up the Health Champion
intervention for people with SMI, and the
implications of decision uncertainty for
commissioning choices.
The economic evaluation will be undertaken using
decision analytic modelling approaches combined with a
review and synthesis of current clinical, economic and
epidemiological evidence (including that generated as
part of the feasibility trial) of relevance to quantifying
the consequences and cost-effectiveness of available de-
cision options concerning scale-up. In support of this
approach, the feasibility trial will be used as an oppor-
tunity to generate additional evidence and information
necessary to support economic modelling.
The scores from the EQ-5D-5L will be used to calcu-
late health-related quality of life changes and for esti-
mating QALY outcomes. We will calculate the costs
associated with the implementation of the intervention
(time of volunteer coordinator and the Health Champions)
and time taken to complete the intervention (by service
users). We will also evaluate the cost of any changes in
wider service user by participants.
Data management
Each participant will be given an identification number.
All information collected will be kept confidential; all
identifiable data will be kept in a locked cabinet or in
password protected documents and forms with identifi-
able data will be kept separate from the outcome data.
Data quality will be enforced by having range checks,
valid values and data double-entry. Any changes to the
protocol will be reported to the research ethics commit-
tee. The final dataset will be accessed by the principal
investigator and the research team. The protocol, the
anonymised participant level dataset and any statistical
codes used will be made available on request.
Discussion
The Health Champions for people with SMI is a novel
and complex intervention, which is based on volunteers
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supporting people who use mental health services with
their physical health. This study will allow us to under-
stand the feasibility of deploying the intervention itself
and also its evaluation suite of measures—which capture
clinical, implementation and health economic elements.
Upon completion of the study, we will have a detailed
overview of whether delivery and planned evaluation ap-
proach are feasible to deliver at the scale that will be re-
quired of a definitive trial; and also whether participants
are able to set and meet goals and feel more in control
of their health, as per the original conceptualisation of
the Health Champions intervention. Importantly, the de-
sign of the study as a hybrid type II trial will allow us to
develop our understanding of how the intervention is
implemented and the challenges in doing this and also
whether the intervention can be sustained. Lastly, the
study will allow us to examine the cost implications of
the intervention, regarding both the cost of the intervention
and its implementation, including how the intervention
may impact on costs elsewhere in the healthcare system.
Improving the physical health of people with SMI is a
high priority in both policy and practice, having been
somewhat neglected in the past. There are currently few
evidence-based interventions to support people with
SMI with their physical health. If this trial is successfully
implemented, it will pave the way for scaled deployment
and evaluation of the Health Champions intervention—
and potentially inspire further interventions of similar
nature for people with SMI to improve their quality of
life.
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